Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 15.54M P/E - EPS this Y - Ern Qtrly Grth -
Income -12.63M Forward P/E - EPS next Y - 50D Avg Chg 28.00%
Sales 113.81k PEG - EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 1.85 EPS next 5Y - 52W High Chg -34.00%
Recommedations - Quick Ratio 0.27 Shares Outstanding 47.35M 52W Low Chg 211.00%
Insider Own 21.31% ROA -29.01% Shares Float 36.92M Beta -
Inst Own 2.92% ROE -92.71% Shares Shorted/Prior -/- Price 0.33
Gross Margin 100.00% Profit Margin - Avg. Volume 3,631 Target Price -
Oper. Margin -5,779.70% Earnings Date - Volume 15,100 Change -8.71%
About NETRAMARK HLDGS INC

NetraMark Holdings Inc. focuses on developing artificial intelligence and machine learning solutions for pharmaceutical and biotechnology companies in Canada. The company develops NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas, a consulting service that helps to discover new drugs, repurpose existing drugs, and resurrect drugs that have failed clinical trials, as well as Nuro app that helps athletes to deal with mental performance. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.